causal

Underfunded Linear Biotech Bets Fail to Adapt

An early investment in a small cancer drug company failed because it was a linear plan with a small team and insufficient funding, leaving no degrees of freedom to adjust when reality diverged from the plan.

causalpending

Speaker

Tal Zaks

Evidence Quote

“this was probably not well enough funded and not given enough opportunity, either with the team structure or the financial structure or the scientific structure to have that degrees and freedom to adjust.”

Source

Bridging Science, Medicine, and Returns— Invest Like the Best
Created: 11/19/2026, 4:01:33 PM

Your notes

Loading notes...